Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederinvestor.lilly.com
Eli Lilly and Company News Releases
Get the latest updates from Eli Lilly and Company News Releases directly as they happen.
Follow now 68 followers
Latest posts
Last updated about 1 hour ago
New Data at EADV 2020 Confirm Taltz® (ixekizumab) Demonstrates Sustained Long-Term Efficacy in Patients with Psoriasis and Psoriatic Arthritis
about 1 hour ago
- Long-term and post-hoc analysis data show continued efficacy of Taltz in...
Data for Lilly's bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of Medicine
about 15 hours ago
INDIANAPOLIS , Oct. 28, 2020 /PRNewswire/ -- The New England Journal of...
Lilly announces agreement with U.S. government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab (LY-CoV555) in an effort to fight COVID-19
1 day ago
- Initial agreement for 300,000 vials with potential for purchase of an...
Lilly Reports Third-Quarter Financial Results, Updates Guidance
2 days ago
- Revenue in the third quarter of 2020 increased 5 percent driven...
New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status
6 days ago
- Jardiance (empagliflozin) reduced risk for the composite endpoint of cardiovascular death...
Lilly Declares Fourth-Quarter 2020 Dividend
10 days ago
INDIANAPOLIS , Oct. 19, 2020 /PRNewswire/ -- The board of directors of...
Lilly Announces Agreement to Acquire Disarm Therapeutics
14 days ago
Acquisition expands Lilly's R&D efforts in pain and neurodegeneration with the addition...
Mirikizumab Shows Continued Symptom Improvement and Reduction of Intestinal Inflammation in Patients with Crohn's Disease in 52-Week Phase 2 Trial
17 days ago
‒ Results from the 52-week study showed continued symptom improvement and reduction...
Lilly's OVERCOME Study Reveals Nearly 80% of People Reported Improvement in Their Migraine Since Starting a CGRP Monoclonal Antibody for Preventive Treatment
20 days ago
- Largest Real-World Study of Patient-Reported Outcomes in People with Migraine Shows...
Lilly Confirms Date and Conference Call for Third-Quarter 2020 Financial Results Announcement
21 days ago
INDIANAPOLIS , Oct. 8, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE...
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
21 days ago
Further results from NIAID-sponsored ACTT-2 Trial Presented Today INDIANAPOLIS , Oct. 8...
Indy Racial Equity Pledge Launches to Drive Accountability, Action and Progress on Racial Equity
21 days ago
Local coalition launches pledge and website, calling on more Central Indiana organizations...